These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 39109735)

  • 1. Anterior lamellar corneoscleral keratoplasty for the management of corneal thinning following treatment with mitomycin-C and interferon to treat highly suspected ocular surface squamous neoplasia: a case report.
    Moreira PPDVR; Longo D; Polisuk M; Carmona TA; Ambrosio R
    Arq Bras Oftalmol; 2024; 88(1):e20230027. PubMed ID: 39109735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The intraoperative use of mitomycin-C in excision of ocular surface neoplasia with or without limbal autograft transplantation.
    Siganos CS; Kozobolis VP; Christodoulakis EV
    Cornea; 2002 Jan; 21(1):12-6. PubMed ID: 11805500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Squamous cell carcinoma of cornea.
    Arya SK; Malik A; Samra SG; Gupta S; Gupta H; Sood S
    Int Ophthalmol; 2008 Oct; 28(5):379-82. PubMed ID: 17898932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular Surface Squamous Neoplasia.
    Vazirani J; Mohapatra S
    JAMA Ophthalmol; 2016 Feb; 134(2):e153666. PubMed ID: 26869128
    [No Abstract]   [Full Text] [Related]  

  • 5. Topical mitomycin C for extensive, recurrent conjunctival-corneal squamous cell carcinoma.
    Shields CL; Naseripour M; Shields JA
    Am J Ophthalmol; 2002 May; 133(5):601-6. PubMed ID: 11992855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitomycin C treatment for conjunctival-corneal intraepithelial neoplasia: a multicenter experience.
    Frucht-Pery J; Sugar J; Baum J; Sutphin JE; Pe'er J; Savir H; Holland EJ; Meisler DM; Foster JA; Folberg R; Rozenman Y
    Ophthalmology; 1997 Dec; 104(12):2085-93. PubMed ID: 9400769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical 0.002% mitomycin C for the treatment of conjunctival-corneal intraepithelial neoplasia and squamous cell carcinoma.
    Prabhasawat P; Tarinvorakup P; Tesavibul N; Uiprasertkul M; Kosrirukvongs P; Booranapong W; Srivannaboon S
    Cornea; 2005 May; 24(4):443-8. PubMed ID: 15829803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical mitomycin C for conjunctival-corneal squamous cell carcinoma.
    Panda A; Bajaj MS; Balasubramanya R; Prakash G
    Am J Ophthalmol; 2003 Jan; 135(1):122-3; author reply 123-4. PubMed ID: 12504721
    [No Abstract]   [Full Text] [Related]  

  • 9. Impression cytology following mitomycin C therapy for ocular surface squamous neoplasia.
    McKelvie PA; Daniell M
    Br J Ophthalmol; 2001 Sep; 85(9):1115-9. PubMed ID: 11520767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical cyclosporine-a combined with mitomycin C for conjunctival and corneal squamous cell carcinoma.
    Tunc M; Erbilen E
    Am J Ophthalmol; 2006 Oct; 142(4):673-5. PubMed ID: 17011863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical mitomycin C for the treatment of conjunctival and corneal epithelial dysplasia and neoplasia.
    Wilson MW; Hungerford JL; George SM; Madreperla SA
    Am J Ophthalmol; 1997 Sep; 124(3):303-11. PubMed ID: 9439356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitomycin C as an adjunct in the treatment of localised ocular surface squamous neoplasia.
    Chen C; Louis D; Dodd T; Muecke J
    Br J Ophthalmol; 2004 Jan; 88(1):17-8. PubMed ID: 14693762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of ocular surface squamous neoplasia with Mitomycin C.
    Gupta A; Muecke J
    Br J Ophthalmol; 2010 May; 94(5):555-8. PubMed ID: 20447963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of conjunctival corneal intraepithelial neoplasia with topical mitomycin C.
    Haas K; Ben-Dor D; Levartovsky S
    Arch Ophthalmol; 1999 Apr; 117(4):544-5. PubMed ID: 10206591
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful treatment of recurrent corneal intraepithelial neoplasia with topical mitomycin C.
    Tseng SH; Tsai YY; Chen FK
    Cornea; 1997 Sep; 16(5):595-7. PubMed ID: 9294697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical mitomycin-C for treatment of partially-excised ocular surface squamous neoplasia.
    Rahimi F; Alipour F; Ghazizadeh Hashemi H; Hashemian MN; Mehrdad R
    Arch Iran Med; 2009 Jan; 12(1):55-9. PubMed ID: 19111031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome of amniotic membrane transplantation combined with mitomycin C for conjunctival reconstruction after ocular surface squamous neoplasia excision.
    Hanada K; Nishikawa N; Miyokawa N; Yoshida A
    Int Ophthalmol; 2017 Feb; 37(1):71-78. PubMed ID: 27061904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of intraepithelial and invasive neoplasia of the cornea and conjunctiva: a long-term follow up.
    Zaki AA; Farid SF
    Cornea; 2009 Oct; 28(9):986-8. PubMed ID: 19724215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superficial keratectomy and topical mitomycin C as therapy for a corneal squamous cell carcinoma in a dog.
    Karasawa K; Matsuda H; Tanaka A
    J Small Anim Pract; 2008 Apr; 49(4):208-10. PubMed ID: 17725585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complications of mitomycin C therapy in 100 eyes with ocular surface neoplasia.
    Khong JJ; Muecke J
    Br J Ophthalmol; 2006 Jul; 90(7):819-22. PubMed ID: 16672325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.